Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries

Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data

(2012) Sarah Tougher et al.   LANCET

Malaria plan under scrutiny

(2012) Amy Maxmen   NATURE

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries

(2011) Megan Littrell et al.   MALARIA JOURNAL

Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia

(2011) Shunmay Yeung et al.   MALARIA JOURNAL

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

(2009) Nicholas J White et al.   MALARIA JOURNAL

Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities

(2008) Christopher JM Whitty et al.   MALARIA JOURNAL